Inventor · disambiguated record
Aran Frank Labrijn
Also filed as: LABRIJN ARAN · LABRIJN ARAN F · LABRIJN ARAN FRANK
36 granted patents·31 pending applications·595 citations·filing 2005–2024
98Inventor score
Top patents by PatentIndex Score
67 records- 0198US11485796B2Inert formatGENMAB AS·Filed 2020·Granted Nov 1, 2022·6 cites·20 claims
- 0297US12049512B2Antibody variants and uses thereofGENMAB BV·Filed 2020·Granted Jul 30, 2024·5 cites·17 claims
- 0397US11866514B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2020·Granted Jan 9, 2024·5 cites·37 claims
- 0497US10597464B2Heterodimeric antibody Fc-containing proteins and methods for production thereofGENMAB AS·Filed 2017·Granted Mar 24, 2020·35 cites·12 claims
- 0597US9150663B2Heterodimeric antibody Fc-containing proteins and methods for production thereofLABRIJN ARAN FRANK·Filed 2011·Granted Oct 6, 2015·119 cites·37 claims
- 0697US7501496B1Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2005·Granted Mar 10, 2009·87 cites·26 claims
- 0796US10590206B2Inert formatGENMAB AS·Filed 2014·Granted Mar 17, 2020·29 cites·20 claims
- 0895US10906991B2Bispecific antibodies and methods for production thereofGENMAB AS·Filed 2015·Granted Feb 2, 2021·15 cites·6 claims
- 0995US10344050B2Production of heterodimeric proteinsGENMAB AS·Filed 2012·Granted Jul 9, 2019·40 cites·52 claims
- 1094US10407501B2Humanized or chimeric CD3 antibodiesGENMAB AS·Filed 2015·Granted Sep 10, 2019·15 cites·19 claims
- 1194US9212230B2Bispecific antibodies and methods for production thereofSCHUURMAN JANINE·Filed 2008·Granted Dec 15, 2015·54 cites·29 claims
- 1293US11492371B2Production of heterodimeric proteinsGENMAB AS·Filed 2019·Granted Nov 8, 2022·9 cites·21 claims
- 1393US10759867B2Antibody variants and uses thereofPARREN PAUL·Filed 2012·Granted Sep 1, 2020·14 cites·6 claims
- 1493US7868141B2Anti-OX40L antibodiesROCHE PALO ALTO LLC·Filed 2008·Granted Jan 11, 2011·21 cites·23 claims
- 1592US11613575B2Humanized or chimeric CD3 antibodiesGENMAB AS·Filed 2019·Granted Mar 28, 2023·4 cites·18 claims
- 1692US9657107B2Monoclonal antibodies against c-MetGENMAB AS·Filed 2015·Granted May 23, 2017·9 cites·25 claims
- 1792US9085625B2Antibody variants having modifications in the constant regionLABRIJN ARAN FRANK·Filed 2009·Granted Jul 21, 2015·31 cites·19 claims
- 1891US11180572B2Dimeric protein with triple mutationsGENMAB BV·Filed 2013·Granted Nov 23, 2021·12 cites·45 claims
- 1991US10465006B2Humanized or chimeric CD3 antibodiesGENMAB·Filed 2014·Granted Nov 5, 2019·18 cites·19 claims
- 2090US9862769B2Monoclonal antibodies against HER2DE GOEIJ BART·Filed 2011·Granted Jan 9, 2018·16 cites·42 claims
- 2190US9102733B2Anti-OX40L antibodiesENDL JOSEPH·Filed 2010·Granted Aug 11, 2015·20 cites·17 claims
- 2288US9068011B2Monoclonal antibodies against c-MetNEIJSSEN JOOST J·Filed 2011·Granted Jun 30, 2015·12 cites·24 claims
- 2386US2024209117A1Heterodimeric antibody fc-containing proteins and methods for production thereofGENMAB AS·Filed 2023·Application pending·0 cites
- 2485US11046771B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Jun 29, 2021·2 cites·23 claims
- 2585US8802089B2Monoclonal antibodies against CD32BVAN DEN BRINK EDWARD NORBERT·Filed 2008·Granted Aug 12, 2014·7 cites·36 claims
- 2685US2025223374A1Antibody variants and uses thereofGENMAB BV·Filed 2024·Application pending·0 cites
- 2784US2025043018A1Antibody variants and uses thereofPARREN PAUL·Filed 2024·Application pending·0 cites
- 2884US2024084036A1Monoclonal antibodies against c-metGENMAB AS·Filed 2022·Application pending·0 cites
- 2983US2023374131A1Humanized or chimeric cd3 antibodiesGENMAB AS·Filed 2023·Application pending·0 cites
- 3082US10351629B2Recombinant IgG4 monovalent antibodiesGENMAB AS·Filed 2016·Granted Jul 16, 2019·2 cites·24 claims
- 3181US11578141B2Bispecific antibodies against HER2 and CD3GENMAB AS·Filed 2019·Granted Feb 14, 2023·1 cites·11 claims
- 3280US11091553B2Monoclonal antibodies against HER2GENMAB AS·Filed 2017·Granted Aug 17, 2021·1 cites·20 claims
- 3380US2025066506A1Bispecific antibodies against her2GENMAB AS·Filed 2024·Application pending·0 cites
- 3479US9322035B2Recombinant IgG4 monovalent antibodiesSCHUURMAN JANINE·Filed 2008·Granted Apr 26, 2016·2 cites·6 claims
- 3579US2023322947A1Inert formatGENMAB AS·Filed 2022·Application pending·0 cites
- 3676US12247065B2Method for producing a controlled mixture of two or more different antibodiesGENMAB AS·Filed 2019·Granted Mar 11, 2025·1 cites·36 claims
- 3776US11512140B2Monoclonal antibodies against c-MetGENMAB AS·Filed 2019·Granted Nov 29, 2022·0 cites·27 claims
- 3876US2025145720A1Human igg1 fc region variants and uses thereofGENMAB BV·Filed 2024·Application pending·0 cites
- 3973US2022169738A1Monoclonal antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 4073US2023227495A1Production of heterodimeric proteinsGENMAB AS·Filed 2022·Application pending·0 cites
- 4172US10000570B2Antibody variants having modifications in the constant regionGENMAB AS·Filed 2015·Granted Jun 19, 2018·1 cites·17 claims
- 4272US2020123255A1Humanized or chimeric cd3 antibodiesGENMAB AS·Filed 2019·Application pending·0 cites
- 4371US9663578B2Monoclonal antibodies against CD32bGENMAB AS·Filed 2014·Granted May 30, 2017·1 cites·16 claims
- 4471US2021155699A1Antibody variants having modifications in the constant regionGENMAB AS·Filed 2020·Application pending·0 cites
- 4568US10865253B2Rodent bispecific heterodimeric proteinsGENMAB AS·Filed 2015·Granted Dec 15, 2020·1 cites·14 claims
- 4667US2021324105A1Bispecific antibodies against her2GENMAB AS·Filed 2021·Application pending·0 cites
- 4762US2017313782A1Monoclonal antibodies against c-metGENMAB AS·Filed 2017·Application pending·0 cites
- 4862US2017320962A1Monoclonal antibodies against c-metGENMAB AS·Filed 2017·Application pending·0 cites
- 4960US2018319888A1Antibody variants having modifications in the constant regionGENMAB AS·Filed 2018·Application pending·0 cites
- 5058US12398214B2Binding agents binding to EpCAM and CD137GENMAB AS·Filed 2023·Granted Aug 26, 2025·0 cites·24 claims
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Aran Frank Labrijn files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →